Schrödinger, Inc. (SDGR) NASDAQ

14.94

-0.86(-5.44%)

Updated at June 02 04:00PM

Currency In USD

Schrödinger, Inc.

Address

1540 Broadway

New York City, NY 10036

United States of America (the)

Phone

212 295 5800

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Employees

891

First IPO Date

February 06, 2020

Key Executives

NameTitlePayYear Born
Ramy FaridChief Executive Officer, President & Director1.32M1965
Richard A. FriesnerCo-Founder, Scientific Advisory Chairman and Director486,8001953
Mannix AklianExecutive VP, Chief Commercial Officer and Global Head of Software Sales & Marketing556,1901975
Robert Lorne AbelExecutive Vice President, Chief Scientific Officer of Platform and Head of Modeling R&D736,8391982
Kenneth Patrick LortonExecutive Vice President, Chief Technology Officer & Chief Operating Officer of Software736,8391984
Richie JainExecutive Vice President, Chief Financial Officer & Treasurer747,9541985
Yvonne TranCorporate Secretary, Chief Legal & People Officer867,4471971
Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships944,2251968
Duncan Hamish WrightSenior Vice President of Translational Science & Therapeutics Business Development0N/A
Lingle WangSenior Vice President of Scientific Development0N/A
Matt RepaskySenior Vice President of Life Sciences Products0N/A
Mike BeachySenior Vice President of Software Development0N/A
Nathalie LacosteSenior Vice President of Life Science Business0N/A
Mathew D. HallsSenior Vice President of Materials Science0N/A
Shane BraunerExecutive Vice President & Chief Information Officer01977
Jaren Irene MaddenChief Corporate Affairs Officer & Head of Investor Relations0N/A
William GoddardCo-Founder & Scientific Advisor0N/A
Therese AbramsPrincipal Accounting Officer01984

Description

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.